• Molecular NameMepenzolate
  • Synonym1-Methyl-3-piperidyl benzilate methyl bromide; Mepenzolate bromide; Mepenzolic acid; N-Methyl-3-piperidyl benzilate methyl bromide; N-Methyl-3-piperidyldiphenylglycolate methobromide
  • Weight340.443
  • Drugbank_IDDB04843
  • ACS_NO76-90-4
  • Show 2D model
  • LogP (experiment)-0.8
  • LogP (predicted, AB/LogP v2.0)-0.72
  • pkaN/A
  • LogD (pH=7, predicted)-0.72
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.6
  • LogSw (predicted, AB/LogsW2.0)100.52
  • Sw (mg/ml) (predicted, ACD/Labs)84.91
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds5
  • TPSA46.53
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antimuscarinic
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A